These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27641953)

  • 21. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
    Radulovic V; Laffin A; Hansson KM; Backlund E; Baghaei F; Jeppsson A
    PLoS One; 2015; 10(7):e0130271. PubMed ID: 26134993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients.
    Nuttall GA; Smith MM; Smith BB; Christensen JM; Santrach PJ; Schaff HV
    Ann Thorac Cardiovasc Surg; 2022 Jun; 28(3):204-213. PubMed ID: 34937821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of a Patient With Antiphospholipid Syndrome Undergoing Aortic Valve Replacement Using the Hepcon Hemostasis Management System Plus and Rotational Thromboelastometry: A Case Report.
    Samejima Y; Kodaka M; Ichikawa J; Mori T; Ando K; Nishiyama K; Komori M
    A A Case Rep; 2017 Mar; 8(5):100-104. PubMed ID: 28098662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Con: Activated Clotting Time Should Not Be Monitored During Heparinization for Vascular Surgery.
    Wolo E; Herman C
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1497-1499. PubMed ID: 29336967
    [No Abstract]   [Full Text] [Related]  

  • 26. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA; Lewis M
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery.
    Ichikawa J; Kodaka M; Nishiyama K; Hirasaki Y; Ozaki M; Komori M
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1003-7. PubMed ID: 24508375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X.
    Hardy JF; Bélisle S; Robitaille D; Perrault J; Roy M; Gagnon L
    J Thorac Cardiovasc Surg; 1996 Jul; 112(1):154-61. PubMed ID: 8691862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device.
    Noui N; Zogheib E; Walczak K; Werbrouck A; Amar AB; Dupont H; Caus T; Remadi JP
    Perfusion; 2012 May; 27(3):214-20. PubMed ID: 22301392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays.
    Murray DJ; Brosnahan WJ; Pennell B; Kapalanski D; Weiler JM; Olson J
    J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):24-8. PubMed ID: 9058215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
    Martindale SJ; Shayevitz JR; D'Errico C
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients.
    D'Errico C; Shayevitz JR; Martindale SJ
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):451-7. PubMed ID: 8776636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept.
    Rochon AG; Bélisle S; Couture P; Fortier A; Lebon JS; Deschamps A
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2369-2374. PubMed ID: 32014311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin monitoring during cardiopulmonary bypass.
    Saleem A; Shenaq SS; Yawn DH; Harshberger K; Diemunsch P; Mohindra P
    Ann Clin Lab Sci; 1984; 14(6):474-9. PubMed ID: 6508227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R; Colby C; El-Etr A; Pifarré R
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time.
    Raymond PD; Ray MJ; Callen SN; Marsh NA
    Perfusion; 2003 Sep; 18(5):269-76. PubMed ID: 14604242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.